New Lung Cancer Approaches Suggested in Mutation Study
Testosterone, the male sex hormone, boosts sexual desire and activities in postmenopausal women, according to a recent study. But a small review published earlier said the effect of the male hormone therapy on the risk of breast cancer remains uncertain. Off-label use of testosterone is allowed in the United States although the FDA has
Full Post: Testosterone patch drives women crazy in bedroom, but cancer risk uncertain
ST. LOUIS, Oct. 22 — Some drugs not previously considered to have potential in lung cancer treatment may, in fact, be helpful in the condition, researchers here said.
Detailed genomic analysis of 188 lung adenocarcinoma specimens revealed mutations in pathways associated with such drugs as rapamycin (Rapamune), sunitinib (Sutent), and sorafenib (Nexavar), reported Li Ding, Ph.D., of Washington University, and colleagues in the Oct. 23 issue of Nature.
The analysis more than doubled the number of genetic defects known to contribute to lung adenocarcinomas, the researchers said. Action Points
Source
Related Posts:
None Found